Compare
Abbott Laboratories vs STAAR Surgical (ABT vs STAA)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and STAAR Surgical (STAA) -0.2%; so far this year the figures are -12.3% and +9.2%.
Abbott Laboratories is the larger company by market value, about 149.9 times the size of STAAR Surgical.
On trailing earnings, ABT trades at 40.9 times and STAA at 2521.0 times.
Revenue grew +10.0% at ABT and +42.4% at STAA over the last year.
ABT yields 2.29%. STAA pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | STAA | |
|---|---|---|
| Price | $109.93 | $25.21 |
| 1-day | -3.23% | -5.65% |
| YTD | -12.26% | +9.18% |
| 1 year | -11.73% | -0.16% |
| 3 years | +15.70% | -41.81% |
| Market cap | $190.4B | $1.3B |
| P/E | 40.9 | 2,521.0 |
| P/S | 3.95 | 3.86 |
| P/B | 3.73 | 3.36 |
| Revenue growth | +10.00% | +42.40% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 73.6 |
| Net margin % | 9.7 | 0.2 |
| ROE % | 9.2 | 0.1 |
| Debt / equity | 0.61 | 0.00 |
| FCF yield % | 3.5 | 1.4 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 0.32 |
| RSI (14) | 58.5 | 58.1 |
| Technical rating |